Back in 2020, Teladoc Health (TDOC -2.03%) was a market darling. The company's business was well adapted to survive -- and even thrive -- amid the worst of the pandemic.
Teladoc Health, Inc. (NYSE:TDOC ) JPMorgan 43rd Annual Healthcare Conference January 13, 2025 7:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Lisa Gill Good afternoon. My name is Lisa Gill, and I head healthcare services here at JPMorgan.
Virtual healthcare company Teladoc Health Inc (NYSE:TDOC) announced a new partnership with e-commerce giant Amazon.com (AMZN), making its diabetes, hypertension, and weight-management programs available on the latter's platform.
Shares of Teladoc Health (TDOC -2.10%) fell 61.6% in 2024, according to data from S&P Global Market Intelligence. The steep price drop continued a negative trend that started with a 54% price cut in 2021 and a 74% plunge in 2022.
Teladoc (TDOC) closed the most recent trading day at $9.52, making no change from the previous trading session.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teladoc Health (TDOC 2.16%) hasn't been an easy stock for investors to hold -- its shares are down by a shocking 88% over the last three years. But few would deny that the company has a substantial amount of real value stemming from its extensive telehealth platform and massive base of subscribers.
Like all companies, Teladoc Health (TDOC 2.16%) will need to evolve a lot over the next three years. The days of the telehealth operator's peak hype are now firmly in the past.
Teladoc Health, Inc. (NYSE:TDOC ) Piper Sandler 36th Annual Healthcare Conference December 3, 2024 12:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Jess Tassan - Piper Sandler Jess Tassan All right, my name is Jess Tassan, I cover healthcare services at Piper. I'm so excited to be here with the Teladoc team CEO, Chuck Divita in his first conference appearance, I think ever since taking the helm, and CFO, Mala Murthy.
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Teladoc Health, Inc. is currently undervalued, trading at 11x forward free cash flow, presenting a compelling investment opportunity despite its dire outlook. The company's strength lies in its scalable virtual healthcare services, with a focus on chronic condition management and international expansion. Stabilizing revenue growth rates to around 1% in 2025 is crucial for Teladoc's valuation and future prospects.
TDOC's use of machine learning and AI continues to drive healthcare innovation.